Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder

Objectives: Describe the safety and tolerability of lisdexamfetamine dimesylate (LDX) and provide data on clinical effects for efficacy-related endpoints and pharmacokinetics in preschool-aged children with attention-deficit/hyperactivity disorder (ADHD). Methods: This phase 2, multicenter, open-lab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Child Adolesc Psychopharmacol
Main Authors: Childress, Ann C., Findling, Robert L., Wu, James, Kollins, Scott H., Wang, Yi, Martin, Patrick, Robertson, Brigitte
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc., publishers 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7153646/
https://ncbi.nlm.nih.gov/pubmed/32233956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2019.0117
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados